Location: Home
  • search
  • go
  • Relate News
  • 7/16/2021Chinese Premier Calls for More Efforts to Enhance BMI Access, Budget M...
  • 7/15/2021Kintor Pharma Ties Up with Fosun for Covid-19 Treatment Proxalutamide ...
  • 7/15/2021HUTCHMED's MAA for Surufatinib Validated by the European Medicines Age...
  • 7/14/2021Innovent and Ascentage Reach Strategic Deal for Olverembatinib in Chin...
  • 7/14/2021Teva's NDA for Copaxone Injection Accepted by the Chinese CDE
  • 7/14/2021AstraZeneca Granted Chinese Approval for New SCLC Indication of Imfinz...
  • 7/13/2021New Report: Global and Chinese CDMO Markets to Rise 11.2% and 19.9% CA...
  • 7/13/2021Kintor Pharma Greenlighted for Pyrilutamide's Phase II Trial in the US
  • 7/13/2021Takeda's NSCLC Drug Mobocertinib NDA Accepted with Priority Review in ...
  • 7/13/2021PharmaDJ's China Market Approval Tracker: May 2021
  • 7/13/2021Nikkei: Avigan Maker Fujifilm Faces Patent Risk from China's AMMS
  • 7/13/2021Seizing Opportunities in China's Healthcare Sector
  • 7/11/2021Shanghai I-Mab  Enters Two New Oncology Partnerships
  • 7/9/2021MOFCOM Plans to Beef Up Scrutinization of Foreign Investment
  • 7/9/2021Takeda's NDA for Mobocertinib (TAK-788) Accepted in China as a Treatme...
  • 7/9/2021Recent Executive Moves
  • 7/9/2021Innovent's NDA for FGFR1/2/3 Inhibitor (Pemigatinib) Accepted in China...
  • 7/8/2021CDE Solicits Comments on the Technical Guidelines for Clinical Pharmac...
  • 7/8/2021Sparx Therapeutics to Build Its First ADC Production Facility in Yangz...
  • 7/8/2021BeiGene/Amgen Wins Chinese Approval of KYPROLIS (Crfilzomib) for r/r M...
  • 7/8/2021Revision of China's Anti-Monopoly Law to Close "Loopholes" in Anti-car...
  • 7/8/2021Is China's Drug Regulator Suddenly Raising the Bar on Cancer Med R&D? ...
  • 7/7/2021dMed-Clinipace Completes US$50M Series C+ Financing
  • 7/6/2021NMPA Announces Package Insert Revision of Metoclopramide Products
  • 7/6/2021Innovent and Laekna Enter a Partnership to Co-Develop Combo of Sinti...
  • 7/6/2021CStone Granted Chinese IND Approval for I/O Candidate CS2006/NM21-14...
  • 7/6/2021Y-mAbs Submits Chinese BLA for DANYELZA® (naxitamab-gqgk)
  • 7/5/2021GSK Launches HIV Drug Dovato (dolutegravir/lamivudine) in China
  • 7/5/2021Nicox Amends Deal with Ocumension with $2M Upfront
  • 7/2/2021NDRC Issues the Implementation Plan for Infrastructural Building of th...
  • Page:90/360 Total number of articles:10791: [First][<<] [88] [89] [90] [91] [92] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group